- Home
- Publications
- Publication Search
- Publication Details
Title
Novel trial designs in neuro-oncology
Authors
Keywords
-
Journal
CURRENT OPINION IN NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-10-22
DOI
10.1097/wco.0000000000001210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the IL4 Receptor with MDNA55 in Patients with Recurrent Glioblastoma: Results of a Phase 2b Trial
- (2023) John H Sampson et al. NEURO-ONCOLOGY
- Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference
- (2023) Rifaquat Rahman et al. LANCET ONCOLOGY
- Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
- (2023) Vivek Subbiah et al. NATURE MEDICINE
- Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
- (2023) Ingo K. Mellinghoff et al. NATURE MEDICINE
- Molecular Profiling in Neuro-Oncology: Where We Are, Where We're Heading, and How We Ensure Everyone Can Come Along
- (2023) Alyx B. Porter et al. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
- Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
- (2023) Rifaquat Rahman et al. JOURNAL OF CLINICAL ONCOLOGY
- Correcting the drug development paradigm for glioblastoma requires serial tissue sampling
- (2023) Kirit Singh et al. NATURE MEDICINE
- The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
- (2023) Nicholas S. Cho et al. Current Oncology Reports
- Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
- (2022) Priscilla K. Brastianos et al. JOURNAL OF CLINICAL ONCOLOGY
- Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
- (2022) Julie J Miller et al. NEURO-ONCOLOGY
- Negative trials over and over again: How can we do better?
- (2022) J Ricardo McFaline-Figueroa et al. NEURO-ONCOLOGY
- The design and evaluation of hybrid controlled trials that leverage external data and randomization
- (2022) Steffen Ventz et al. Nature Communications
- The use of external control data for predictions and futility interim analyses in clinical trials
- (2021) Steffen Ventz et al. NEURO-ONCOLOGY
- Leveraging external data in the design and analysis of clinical trials in neuro-oncology
- (2021) Rifaquat Rahman et al. LANCET ONCOLOGY
- Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial
- (2021) Patrick Y Wen et al. LANCET ONCOLOGY
- Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
- (2021) François Doz et al. NEURO-ONCOLOGY
- Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
- (2020) Patrick Y Wen et al. NEURO-ONCOLOGY
- Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review
- (2020) Michael A Vogelbaum et al. NEURO-ONCOLOGY
- Randomised controlled trials versus real world evidence: neither magic nor myth
- (2020) Hans‐Georg Eichler et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Informing single-arm clinical trials with external controls
- (2020) Ruthie Davi et al. NATURE REVIEWS DRUG DISCOVERY
- Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
- (2019) Steffen Ventz et al. CLINICAL CANCER RESEARCH
- Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
- (2019) Nader Sanai NEUROSURGERY
- INNV-33. BARRIERS TO ACCRUAL AND ENROLLMENT IN BRAIN TUMOR TRIALS
- (2019) Eudocia Lee et al. NEURO-ONCOLOGY
- Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients
- (2018) Nader Sanai et al. CLINICAL CANCER RESEARCH
- The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?
- (2018) Alyssa M Vanderbeek et al. NEURO-ONCOLOGY
- OUP accepted manuscript
- (2018) NEURO-ONCOLOGY
- BRAF Inhibition in BRAFV600-Mutant Gliomas: Results From the VE-BASKET Study
- (2018) Thomas Kaley et al. JOURNAL OF CLINICAL ONCOLOGY
- Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma
- (2017) Stuart A. Grossman et al. NEURO-ONCOLOGY
- The Platform Trial
- (2015) Scott M. Berry et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials
- (2010) Hui Tang et al. JOURNAL OF CLINICAL ONCOLOGY
- Designing Phase 0 Cancer Clinical Trials
- (2008) A. J. Murgo et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started